|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.45 CHF | -0.25% |
|
-2.29% | -5.38% |
| Apr. 26 | Switzerland's BB Biotech Swings to Q1 Profit; Operating Income Jumps | MT |
| Apr. 25 | BB Biotech AG Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
BB Biotech AG reported earnings results for the full year ended December 31, 2022. For the full year, the company reported revenue was CHF 1.26 million compared to CHF 0.004 million a year ago. Net loss was CHF 357.81 million compared to CHF 404.81 million a year ago.
Basic loss per share from continuing operations was CHF 6.5 compared to CHF 7.31 a year ago. Diluted loss per share from continuing operations was CHF 6.5 compared to CHF 7.31 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -5.38% | 2.43B | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
BB BIOTECH AG 
